Literature DB >> 23765277

Crystal structure of NLRC4 reveals its autoinhibition mechanism.

Zehan Hu1, Chuangye Yan, Peiyuan Liu, Zhiwei Huang, Rui Ma, Chenlu Zhang, Ruiyong Wang, Yueteng Zhang, Fabio Martinon, Di Miao, Haiteng Deng, Jiawei Wang, Junbiao Chang, Jijie Chai.   

Abstract

Nucleotide-binding and oligomerization domain-like receptor (NLR) proteins oligomerize into multiprotein complexes termed inflammasomes when activated. Their autoinhibition mechanism remains poorly defined. Here, we report the crystal structure of mouse NLRC4 in a closed form. The adenosine diphosphate-mediated interaction between the central nucleotide-binding domain (NBD) and the winged-helix domain (WHD) was critical for stabilizing the closed conformation of NLRC4. The helical domain HD2 repressively contacted a conserved and functionally important α-helix of the NBD. The C-terminal leucine-rich repeat (LRR) domain is positioned to sterically occlude one side of the NBD domain and consequently sequester NLRC4 in a monomeric state. Disruption of ADP-mediated NBD-WHD or NBD-HD2/NBD-LRR interactions resulted in constitutive activation of NLRC4. Together, our data reveal the NBD-organized cooperative autoinhibition mechanism of NLRC4 and provide insight into its activation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23765277     DOI: 10.1126/science.1236381

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  156 in total

1.  Structure and assembly of the mouse ASC inflammasome by combined NMR spectroscopy and cryo-electron microscopy.

Authors:  Lorenzo Sborgi; Francesco Ravotti; Venkata P Dandey; Mathias S Dick; Adam Mazur; Sina Reckel; Mohamed Chami; Sebastian Scherer; Matthias Huber; Anja Böckmann; Edward H Egelman; Henning Stahlberg; Petr Broz; Beat H Meier; Sebastian Hiller
Journal:  Proc Natl Acad Sci U S A       Date:  2015-10-13       Impact factor: 11.205

2.  Inflammasome assembly: The wheels are turning.

Authors:  Petr Broz
Journal:  Cell Res       Date:  2015-11-24       Impact factor: 25.617

3.  The NLRP6 Inflammasome Recognizes Lipoteichoic Acid and Regulates Gram-Positive Pathogen Infection.

Authors:  Hideki Hara; Sergey S Seregin; Dahai Yang; Koichi Fukase; Mathias Chamaillard; Emad S Alnemri; Naohiro Inohara; Grace Y Chen; Gabriel Núñez
Journal:  Cell       Date:  2018-11-01       Impact factor: 41.582

Review 4.  Emerging significance of NLRs in inflammatory bowel disease.

Authors:  Beckley K Davis; Casandra Philipson; Raquel Hontecillas; Kristin Eden; Josep Bassaganya-Riera; Irving C Allen
Journal:  Inflamm Bowel Dis       Date:  2014-12       Impact factor: 5.325

Review 5.  Regulation of inflammasome activation.

Authors:  Si Ming Man; Thirumala-Devi Kanneganti
Journal:  Immunol Rev       Date:  2015-05       Impact factor: 12.988

Review 6.  Pyroptotic cell death defends against intracellular pathogens.

Authors:  Ine Jorgensen; Edward A Miao
Journal:  Immunol Rev       Date:  2015-05       Impact factor: 12.988

Review 7.  The nucleic acid-sensing inflammasomes.

Authors:  Tsan Sam Xiao
Journal:  Immunol Rev       Date:  2015-05       Impact factor: 12.988

8.  The NLRP3 inflammasome contributes to host protection during Sporothrix schenckii infection.

Authors:  Amanda Costa Gonçalves; Lucas Souza Ferreira; Francine Alessandra Manente; Carolina Maria Quinello Gomes de Faria; Marisa Campos Polesi; Cleverton Roberto de Andrade; Dario Simões Zamboni; Iracilda Zeppone Carlos
Journal:  Immunology       Date:  2017-03-03       Impact factor: 7.397

9.  The Scaffolding Protein IQGAP1 Interacts with NLRC3 and Inhibits Type I IFN Production.

Authors:  Aaron M Tocker; Emily Durocher; Kimberly D Jacob; Kate E Trieschman; Suzanna M Talento; Alma A Rechnitzer; David M Roberts; Beckley K Davis
Journal:  J Immunol       Date:  2017-09-01       Impact factor: 5.422

10.  Molecular basis for specific recognition of bacterial ligands by NAIP/NLRC4 inflammasomes.

Authors:  Jeannette L Tenthorey; Eric M Kofoed; Matthew D Daugherty; Harmit S Malik; Russell E Vance
Journal:  Mol Cell       Date:  2014-03-20       Impact factor: 17.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.